Our findings suggest that SOSC might be an essential inducible factor in the protection against 3-NPA-induiced striatal cell death, strongly suggesting its potential therapeutic role in treating HD via Nrf2-HO-1 pathway regulation. This evidence concerns the gene NFE2L2 and Huntington disease.